The forecasted sales of analgesic medicine in Austria show a consistent year-on-year growth from 2024 to 2028, starting at 114.2 million USD in 2024 and reaching 142.9 million USD by 2028. In 2023, the sales were at 107 million USD. The year-on-year percentage variations demonstrate a steady increase of approximately 6.3% from 2024 to 2025, and an average annual growth rate (CAGR) of around 5.9% over the five-year period.

Future trends to watch for include:

The impact of new pain management therapies and innovations entering the market.
Shifts in consumer preferences towards natural or alternative remedies.
Regulatory changes that could affect market dynamics.
Aging population trends and their influence on demand for analgesic medications.